LDR | |
00963cam a2200289 a 4500 |
001 |
|
011326986 |
003 |
|
MiAaHDL |
005 |
|
20160303000000.0 |
006 |
|
m d |
007 |
|
cr bn ---auaua |
008 |
|
840720s1984 mduak b f00000 eng d |
035 |
⊔ |
⊔ |
‡asdr-ucr.b10341225
|
035 |
⊔ |
⊔ |
‡asdr-pur1733227
|
040 |
⊔ |
⊔ |
‡aGPO
‡cGPO
|
043 |
⊔ |
⊔ |
‡an-us---
|
049 |
9 |
9 |
‡aRECLAMATION
|
074 |
⊔ |
⊔ |
‡a507-G-2
|
086 |
0 |
⊔ |
‡aHE 20.3152:H 88
|
098 |
⊔ |
⊔ |
‡aHE203152H88
|
099 |
⊔ |
8 |
‡aHE 20.3152:H 88
|
035 |
⊔ |
⊔ |
‡a(OCoLC)10985966
|
245 |
0 |
0 |
‡aApplication of a human tumor colony forming assay to new drug screening.
|
260 |
0 |
⊔ |
‡a[Bethesda, Md. :
‡bNational Institutes of Health, National Cancer Institute],
‡c1984.
|
300 |
⊔ |
⊔ |
‡a519 p. :
‡bill., forms ;
‡c28 cm.
|
538 |
⊔ |
⊔ |
‡aMode of access: Internet.
|
650 |
⊔ |
0 |
‡aTumor antigens
‡xResearch
‡zUnited States.
|
650 |
⊔ |
0 |
‡aDrugs
‡xTesting
‡xResearch
‡zUnited States.
|
710 |
2 |
0 |
‡aNational Cancer Institute (U.S.)
|
CID |
⊔ |
⊔ |
‡a011326986
|
DAT |
0 |
⊔ |
‡a19921101130331.0
‡b20160303000000.0
|
DAT |
1 |
⊔ |
‡a20160304090626.0
‡b2024-09-08T17:56:27Z
|
DAT |
2 |
⊔ |
‡a2024-09-08T17:30:02Z
|
CAT |
⊔ |
⊔ |
‡aSDR-UCR
‡dIII - MILLENIUM
‡lprepare.pl-004-004
|
FMT |
⊔ |
⊔ |
‡aBK
|
HOL |
⊔ |
⊔ |
‡0sdr-ucr.b10341225
‡auc1
‡bSDR
‡cUCR
‡puc1.31210023585050
‡sUC
‡1.b10341225
|
974 |
⊔ |
⊔ |
‡bUC
‡cUCR
‡d20240908
‡sgoogle
‡uuc1.31210023585050
‡y1984
‡rpd
‡qbib
‡tUS fed doc
|
974 |
⊔ |
⊔ |
‡bPUR
‡cPUR
‡d20240929
‡sgoogle
‡upur1.32754076099906
‡y1984
‡rpd
‡qbib
‡tUS fed doc
|